Tobacco control, especially in the context of rising use and health harms associated with unregulated illegal drugs over the same time span, is one key aspect of drug policy where the UK has not been shockingly poor by global standards (significantly because it has been approached primarily as a public health challenge led by health agencies, rather than an enforcement challenge led by the Home Office)
This situation raises concerns among anti-tobacco advocates and local retailers about potential revenue loss
Where else in medicine is the standard of care from 20 years ago good enough? The task of bringing the RespiRx to market falls to Brian Quigley, Qnovias CEO, who formerly led Altrias smokeless products division (Danek now serves as chief technology officer)
This demonstration highlights the devastating harms caused by every cigarette and helps people see that vaping is likely to pose only a fraction of the risk. PHE says the risks from vaping are tiny compared to smoking
Merchandise smarter with 20 black Lozier gondola shelves that adjust vertically to fit your needs
By now, you are likely aware of many of the well-established risks associated with smoking cigarettes, such as cancer, asthma, chronic obstructive pulmonary disease (COPD), diabetes, cardiovascular disease, and stroke